u.s. biotech for a month last year was defiant defending the takeover as the right move. however the company currently faces thousands of lawsuits in the u.s. over possible cancer risks. there's no way to gloss this over the lawsuits and the initial verdicts on life a safe have weighed heavily on our company and there unsettling many people. are feeling mentioned they're also unsettled by a number of studies the world health organization says and one that glyphosate is a potential concert risk while other scientists concludes that guy for sage is not carcinogenic one thing is certain the destruction of buyer's market cap since the monsanto acquisition as its stock price collapses there's deep mistrust of the company both inside and outside of the pond masing right now the value of what was once germany's most valuable listed chemical company is only around fifty seven billion euros which is pretty much exactly what buyer paid for months on tow over to the u.s. which has posted its strongest first quarter growth in four years economy expanded three point two percent far exc

u.s. markets now, we are up about 1% for the equity indices. the nasdaq biotechp about 0.5%, not as strong as the rest. guy. on: european markets risk coming out of asia. that strong pmi data over the weekend the and augmented by the strong ism numbers out of the united states. , reallyoutperforming gaining on the china news. this is bloomberg. ♪ guy: 30 seconds to go until the end of regular training here in europe. strong risk on the sentiment story. germany outperforming, but bright green throughout most of europe. putcent performance being forward by the miners today. data we saw out of the chinese economy over the weekend, both official and passion of pmi data showing signs of strength. let's initially with the equity markets look like and give you an idea of what is going on. we have seen outperform is coming through on the dax today. the auto stocks have been the leader. theas actually been some of supply chain stocks that have done well. the dax up 1.5%. lagon, a little bit of a edit exit story and what has been happening with the airlines. easyjet to the

u.s. would peg prices for these expensive drugs to 16 or 18 nations. japan, canada, france, and so i think that's something that the pharmaceutical and biotech industry areir breath on. it will be a little bit more than symbolic. >> bill george good discussion on a hot topic many americans care about this we'll chat with you soon >> thanks, brian >> thank you >>> oil's big run continuing again today. yet another new high right now for crude oil. now crude's run has helped the stock market so far this year according to cramer. is there going to be a breaking point at some point? plus, you won't believe the new size of saudi aramco's debt sale benjamin netanyahu facing voters today as he seeks a fifth term hadley gamble live in tel aviv hadley >> that's right, brian it's shaping up to be the fight of benjamin netanyahu's political life he is neck and neck in the polls leading into this election with his newest opponent. we'll have more on that when wor worldwide exchange returns it was here. i couldn't catch my breath. it was the last song of the night. it felt like my heart was skipping beats. they said i had afib. what's afib? i knew that meant i was at

if china has a trade go with the u.s., one of the agreement would be that they would be opening up in china. we don't know where the trade deal will be happening. biotech approval here. record highs for the stock. 897. this will be the first stop in we will have plenty more coming up, this is bloomberg. ♪ so with xfinity mobile i can customize each line for each family member? yup. and since it comes with your internet, you can switch wireless carriers, and save hundreds of dollars a year. are you pullin' my leg? nope. you sure you're not pullin' my leg? i think it's your dog. oh it's him. good call. get the data options you need, and still save hundreds of dollars. do you guys sell other dogs? now that's simple, easy, awesome. customize each line by paying for data by the gig or get unlimited. and now get $250 back when you buy a new samsung galaxy. click, call, or visit a store today. >> we are in the middle of the trading day. singapore is what market that is tracking a little bit lower today. this index is up by about one third of 1%. you have seen a bit of upside coming through. also, the capital land mall trust. let's get the first word headlines

in the u.s., but also globally, and even the product that's made in 2023, we wouldn't use that in 2023 we would use that in the years beyond that. so from a supply perspective, for a small biotech, we're in really good shape from an inventory and commercial perspective. >> i care about the patient side and don't want to hear you could be cut off once people get started. $7,000 a year for amavig similar type pricing >> i think that will be a benchmark. we're working through a health economic data right now because we think we have advantages in terms potentially in robustness of response and the whole speed to response, and payers are excited by after a quarter, you'll have a pretty good idea whether or not it works for the patient. >> absolutely. how about awareness of the issue, in 36 million sufferers >> so that's one thing that we're passionate about from the alder perspective, is the education element of it. even more so, i don't think people have a really good understanding of what it means to have chronic migraine and so we're really focused on that particular education, and most people think it's a headache, but when you think about the light sensitivity, sound sensitivi